1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Olopatadine |
| brand | String | Patanol, Pataday (ophthalmic, now OTC), Patanase (intranasal) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:H1_receptor_antagonists|Histamine H1 receptor antagonist]] • [[:Category:Mast_cell_stabilizers|Mast cell stabilizer]] • [[:Category:Ophthalmic_antihistamines|Ophthalmic antihistamine]] |
| mechanism | String | '"`UNIQ--vote-000011D5-QINU`"' Minimal systemic absorption and the dual mechanism underlie its first-line role in seasonal allergic conjunctivitis. Comfort drops without preservatives are available for sensitive patients'"`UNIQ--ref-000011D6-QINU`"'. |
| uses | String | '"`UNIQ--vote-000011D7-QINU`"', '"`UNIQ--vote-000011D8-QINU`"' |
| starting_dose | String | Ophthalmic Pataday 0.7%: 1 drop in each eye once daily (24-hour formulation); Patanol 0.1% BID; intranasal Patanase 2 sprays/nostril BID |
| preparations | String | 0.1% (Patanol), 0.2% (Pataday once-daily original), 0.7% (Pataday 24-hour) ophthalmic solutions; 0.6% nasal spray |
| fda_max | String | Once daily (Pataday 0.7%); BID (other ophthalmic) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical ophthalmic • intranasal |
| onset | String | Symptom relief within 30-60 minutes |
| duration | String | 24 hours (0.7% formulation); 8-12 hours (lower-strength) |
| halflife | String | ~3 hours (systemic, when measurable; topical action dominates)'"`UNIQ--ref-000011D9-QINU`"' |
| bioavailability | String | Topical with minimal systemic absorption'"`UNIQ--ref-000011DA-QINU`"' |
| pregnancy | String | Generally considered safe; minimal systemic exposure.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | OTC (Pataday ophthalmic) and [[USLegal:Prescription only|Rx-only]] (Patanase intranasal) in US |
